<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>â€ƒ We present the case of a 3-month-old child with probable catastrophic <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> who, after initial successful management with immunomodulary therapies including rituximab, experienced a cutaneous relapse </plain></SENT>
<SENT sid="1" pm="."><plain>This rare event was successfully re-treated with repeated administration of rituximab, supporting its role in the control of this disorder </plain></SENT>
<SENT sid="2" pm="."><plain>Dermatologic manifestations may be the main clinical presentation of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, a possible underdiagnosed but potentially fatal pathology </plain></SENT>
</text></document>